Try our Advanced Search for more refined results

Amgen Deal Struck As Tide Turns To Looser Off-Label Limits

By Sindhu Sundar (August 19, 2015, 8:13 PM EDT) -- Amgen Inc.'s $71 million multistate deal for off-label promotion follows a familiar pattern of settlements with states for a fraction of an earlier federal deal, but attorneys say the recent Amarin Pharma Inc. decision supporting wider commercial speech will change that dynamic by giving companies more leverage in future marketing disputes....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!